VK2735 makes Viking Therapeutics an attractive buyout candidate or big pharma partner. Its oral formulation reported good ...

Viking Therapeutics is primed for acquisition due to its robust pipeline and potential as a market disruptor. Find out why ...

Key Insights Significantly high institutional ownership implies Viking Therapeutics' stock price is sensitive to ...

In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 783.0 with a total ...

The post 7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 appeared first on InvestorPlace.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in Russell 2000 stocks is a smart idea because it ...

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PROCEPT BioRobotics (PRCT – Research ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024 ...

Ligand Pharmaceuticals Incorporated (LGND) announced that its partner Viking Therapeutics, Inc. (“Viking”) (NASDAQ:VKTX) today announced positive top-line results from its Phase 2b ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...